The Amplification Loop of the Complement Pathways

被引:180
作者
Lachmann, Peter J. [1 ]
机构
[1] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England
来源
ADVANCES IN IMMUNOLOGY, VOL 104 | 2009年 / 104卷
关键词
HEMOLYTIC-UREMIC SYNDROME; GLOMERULONEPHRITIS TYPE-II; MEMBRANE COFACTOR PROTEIN; FACTOR-H DEFICIENCY; MACULAR DEGENERATION; AMYLOID-BETA; FACTOR-B; NEPHRITIC FACTOR; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; ALZHEIMERS-DISEASE;
D O I
10.1016/S0065-2776(08)04004-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The C3 amplification loop lies at the core of all the complement pathways, rather than the alternative pathway alone. It is, in evolutionary terms, the oldest part of the complement system and its antecedents can be seen in insects and in echinoderms. The amplification loop is the balance between two competing cycles both acting on Ob: the C3 feedback cycle which enhances amplification and the C3 breakdown cycle which downregulates it. It is solely the balance between their rates of reaction on which amplification depends. The C3 breakdown cycle generates iC3b as its primary reaction product. iC3b, through its reaction with the leukocyte integrins (and complement receptors) CR3 (CD11b/CD18) and CR4 (CD11c/CD18), is the most important mechanism by which complement mediates inflammation. A variety of genetic polymorphisms in components of the amplification loop have been shown to predispose to two kidney diseases-dense deposit disease and atypical haemolytic uraemic syndrome-and to age-related macular degeneration. All predisposing alleles enhance amplification, whereas protective alleles downregulate amplification. This leads to the conclusion that there is a "hyperinflammatory complement phenotype" determined by these polymorphisms. This hyperinflammatory phenotype protects against bacterial infections in early life but in later life is associated with immunopathology. Besides the diseases already mentioned, there is evidence that this hyperinflammatory complement phenotype may predispose to accelerated atherosclerosis and also shows an association with Alzheimer's disease. Downregulation of the amplification loop therefore constitutes an important therapeutic target.
引用
收藏
页码:115 / 149
页数:35
相关论文
共 118 条
[1]  
AEGERTERSHAW M, 1987, J IMMUNOL, V138, P3488
[2]  
ALPER CA, 1972, LANCET, V2, P1179
[3]   STUDIES IN-VIVO AND IN-VITRO ON AN ABNORMALITY IN METABOLISM OF C3 IN A PATIENT WITH INCREASED SUSCEPTIBILITY TO INFECTION [J].
ALPER, CA ;
ABRAMSON, N ;
JOHNSTON, RB ;
JANDL, JH ;
ROSEN, FS ;
WATSON, L .
JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (11) :1975-&
[4]   Interaction Between the Coagulation and Complement System [J].
Amara, Umme ;
Rittirsch, Daniel ;
Flierl, Michael ;
Bruckner, Uwe ;
Klos, Andreas ;
Gebhard, Florian ;
Lambris, John D. ;
Huber-Lang, Markus .
CURRENT TOPICS IN COMPLEMENT II, 2008, 632 :71-79
[5]   A family with complement factor D deficiency [J].
Biesma, DH ;
Hannema, AJ ;
van Velzen-Blad, H ;
Mulder, L ;
van Zwieten, R ;
Kluijt, I ;
Roos, D .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (02) :233-240
[6]   Antimalarial responses in Anopheles gambiae:: From a complement-like protein to a complement-like pathway [J].
Blandin, Stephanie A. ;
Marois, Eric ;
Levashina, Elena A. .
CELL HOST & MICROBE, 2008, 3 (06) :364-374
[7]   ISOLATION AND PROPERTIES OF A GLYCINE-RICH BETA-GLYCOPROTEIN OF HUMAN SERUM [J].
BOENISCH, T ;
ALPER, CA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1970, 221 (03) :529-&
[8]   HOMOZYGOUS HEREDITARY C3 DEFICIENCY DUE TO A PARTIAL GENE DELETION [J].
BOTTO, M ;
FONG, KY ;
SO, AK ;
BARLOW, R ;
ROUTIER, R ;
MORLEY, BJ ;
WALPORT, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) :4957-4961
[9]  
Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297
[10]   FLUID-PHASE INTERACTION OF C1BAR INHIBITOR (C1BARINH) AND THE SUB-COMPONENTS C1BARR AND C1BARS OF THE 1ST COMPONENT OF COMPLEMENT, C1BAR [J].
CHESNE, S ;
VILLIERS, CL ;
ARLAUD, GJ ;
LACROIX, MB ;
COLOMB, MG .
BIOCHEMICAL JOURNAL, 1982, 201 (01) :61-70